NG-MAST ST (No. of isolates) | Drug | No. of isolates with MIC (mg/L): | penA | ||||
---|---|---|---|---|---|---|---|
alterationa | |||||||
≤0.016 | 0.032 | 0.064 | 0.125 | 0.25 |  | ||
1407 (58) | IX | Â | 4 | 30 | 24 | Â | 58 (100%) mosaic |
TX | 4 | 18 | 27 | 9 | Â | ||
2992 (17) | IX | 17 | Â | Â | Â | Â | 17 (100%) WT |
TX | 17 | Â | Â | Â | Â | ||
1405 (12) | IX | 3 | 8 | 1 | Â | Â | 12 (100%) A501V |
TX | 2 | 6 | 4 | Â | Â | ||
1861 (10) | IX | 5 | 5 | Â | Â | Â | 10 (100%) WT |
TX | 1 | 4 | 5 | Â | Â | ||
8392 (8)b | IX | 8 | Â | Â | Â | Â | 8 (100%) WT |
TX | 8 | Â | Â | Â | Â | ||
8379 (8)b | IX | 8 | Â | Â | Â | Â | 8 (100%) WT |
TX | 6 | 2 | Â | Â | Â | ||
8391 (7)b | IX | 7 | Â | Â | Â | Â | 7 (100%) WT |
TX | 7 | Â | Â | Â | Â | ||
5421 (7) | IX | 7 | Â | Â | Â | Â | 7 (100%) WT |
TX | 7 | Â | Â | Â | Â | ||
8370 (6) | IX | 6 | Â | Â | Â | Â | 6 (100%) WT |
TX | 6 | Â | Â | Â | Â | ||
1478 (5) | IX | 5 | Â | Â | Â | Â | 5 (100%) WT |
TX | 5 | Â | Â | Â | Â | ||
7674 (5) | IX | 5 | Â | Â | Â | Â | 5 (100%) WT |
TX | 5 | Â | Â | Â | Â | ||
21 (5) | IX | 4 | 1 | Â | Â | Â | 5 (100%) WT |
TX | 2 | 1 | 2 | Â | Â | ||
STs with 2-4 isolates (42)c | IX | 30 | 6 | 4 | 2 | Â | 8 (19%) mosaic; 34 (81%) WT |
TX | 31 | 6 | 5 | Â | Â | ||
Unique STs (38)d | IX | 28 | 3 | 5 | 2 | Â | 10 (26%) mosaic; 1 (2.6%) A501V; 1 (2.6%) A501T; 26 (68%) WT |
TX | 28 | 4 | 4 | 2 | Â |